Accendra Health, Inc. (ACCH) stock analysis
Healthcare · Medical Distribution
From the 10-K filed 2026-02-20
Business type: Treadmill
How it makes money
Accendra Health generates revenue via fee-for-service and capitation arrangements, with its two largest commercial payors contributing approximately 23% and 14%.
Accendra Health earns revenue through its Apria and Byram Healthcare brands by renting and selling medical supplies and equipment for home care. Key product categories include Diabetes, Sleep therapy, Home respiratory therapy, Ostomy, Wound care, and Urology. Payments are received from commercial managed care plans, Medicare, state Medicaid programs, and direct patient co-payments under fee-for-service and capitated arrangements.
Earnings are heavily concentrated among top payors: in 2025, its two largest commercial payors represented 23% and 14% of net revenue, while Medicare and Medicaid accounted for 19%. Profitability is driven by maintaining referral volumes from hospitals and physicians, managing payor reimbursement rates, and controlling medical equipment procurement costs.
What protects it: the moat
Accendra Health relies on its Apria and Byram Healthcare brands and internal billing expertise to navigate complex payor reimbursement requirements and reduce claim denials.
Accendra Health defends its market position through the established reputation of its Apria and Byram Healthcare brands, alongside customized operational technology. Management asserts a low-cost operator position, using web portals, electronic ordering, electronic claims submissions, and electronic funds transfers to streamline transactions with managed care organizations.
In addition, the company maintains internal specialized billing expertise to navigate payor reimbursement rules and simplify claims processing. This capabilities framework aims to shorten collection periods, lower administrative costs for payors, and reduce claim denial rates relative to smaller competitors.
What growth costs
Accendra Health incurred $18 million in net exit and realignment charges alongside an $80 million transaction breakage fee to terminate its Rotech acquisition.
To sustain and expand operations, Accendra Health regularly spends capital on inventory, patient service equipment depreciation, information technology, and clinical field support. In 2025, cost of products sold reached $1,323,336 thousand and patient service equipment depreciation totaled $126,830 thousand, driven by commercial expansion initiatives such as its Sleep Journey Initiative.
Restructuring and strategic integration expenses represent major cash outflows. The business incurred $18 million in net exit and realignment charges during 2025 for IT initiatives, facility wind-downs, and organizational severance. Furthermore, corporate expansion plans stalled when Accendra Health paid an $80 million cash breakage fee to terminate its proposed acquisition of Rotech Healthcare Holdings.
What could damage it
A commercial payor contract termination eliminates $322 million or 12% of net revenue, destroying nearly all $231 million of its capitation revenue.
Accendra Health faces significant structural vulnerability from concentration among commercial health plans. If a major payor terminates its contracts, the business immediately loses high-margin volume, suffers asset write-downs, and must rapidly scale back operational costs.
This exact causal mechanism materialized when a commercial payor began non-renewing contracts representing $322 million, or 12% of 2025 net revenue. The cancellation stripped away $231 million of capitation revenue—virtually all of the company's capitated earnings stream—triggering useful-life modifications and accelerated amortization on acquired customer relationship intangible assets.
About Accendra Health, Inc.
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.